Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 8, 2009 - Issue 1
Submit an article Journal homepage
108
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Cisplatin–vinorelbine chemotherapy in non-small cell lung cancer is safe and well tolerated: results of a retrospective Hungarian clinical data analysis

Mária Szilasi Medical University, Department of Pulmonology, Debrecen, Hungary
,
Veronika Müller Semmelweis University, Department of Pulmonology, Budapest, Hungary
,
Erzsébet Juhász National Korányi Tuberculosis and Lung Disease, Budapest, Hungary
,
Pál Magyar Semmelweis University, Department of Pulmonology, Budapest, Hungary
,
Marianna Budai Semmelweis University, Department of Pharmaceutics, Budapest, Hungary
&
Lilla Tamási Semmelweis University, Department of Pulmonology, 1125-Diós árok 1c, Budapest, Hungary +36 20 920 9796; +36 1 214 2498; [email protected]
Pages 9-14 | Published online: 18 Dec 2008

Bibliography

  • Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin 2008;58:71-96
  • Farjah F, Wood DE, Yanez D III, et al. Temporal trends in the management of potentially resectable lung cancer. Ann Thorac Surg 2008;85(6):1850-5
  • Ponn RB, Cicero J III, Daly BDT. Surgical treatment of nonsmall cell lung cancer. In: Shields TW, Lo Cicero, Ponn R, et al, editors. General thoracic surgery. 6th edition. Philadelphia: Lippincott Williams and Wilkins 2005;1548-87
  • Scott WJ, Howington J, Feigenberg S, et al. American College of Chest Physicians. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines 2nd edition. Chest 2007;132:234-42
  • Le Chevalier T, Brisgand D, Douillard JY, et al. Randomized study of vinorelbine and cisplatin vs. vindesine and cisplatine vs. vinorelbine alone in advanced non-small cell lung cancer: result of a European multicenter trial including 612 patients. J Clin Oncol 1994;12:360-7
  • National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: non-small cell lung cancer. V.2.2008. Available from: www.nccn.org [Last accessed 29 June 2008]
  • Winton T, Livingston R, Johnson D, et al. National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators. Vinorelbine plus cisplatine vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-97
  • Gatzemeier U, Pluzanska A, Szczesna A, et al. Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the tarceva lung cancer investigation trial. J Clin Oncol 2007;25:1545-52
  • Gridelli C, Maione P, Rossi A, et al. Chemotherapy of advanced NSCLC in special patient population. Ann Oncol 2006;17:72-8
  • Gridelli C, Perrone F, Gallo C, et al. Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. Eur J Cancer 1997;33:392-7
  • Costa GJ, Fernandes AL, Pereira JR, et al. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC). Lung Cancer 2006;53:171-6
  • Ostoros G, Szondy K, Gergely-Farnos E, et al. Efficacy of gemcitabine-cisplatin treatment in stage IIIA (“bulky”N2), IIIB and IV non-small cell lung cancer. Anticancer Res 2005;25:471-5
  • Dimitroulis J, Toubis M, Antoniou D, et al. Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a Phase II study. Anticancer Res 2006;26:1397-402
  • Ohe Y, Ohashi Y, Kubota K, et al. Randomized Phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol 2007;18:317-23
  • Martoni A, Marino A, Sperandi F, et al. Multicentre randomised Phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer. Eur J Cancer 2005;41:81-92
  • Survelliance, Epidemiology, and End Results (SEER): cancer statistics review 1975-2004, National Cancer Institute. Bethesda, MD. Available from: www.seer.cancer.gov/csr/1975_2004 [Last accessed 29 June 2008]
  • Chen YM, Perng RP, Shih JF, Whang-Peng J. A Phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly. 2008;61(2):214-9. Epub 2008 Feb 19
  • Gridelli C, Maione P, Illiano A, et al. Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies. J Clin Oncol 2007;25:4663-9
  • Früh M, Rolland E, Pignon JP, et al. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer. J Clin Oncol 2008;26:3573-81
  • Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006;7(9):719-27

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.